Review ArticleIndian Journal of Pharmacy PracticeVol. 18 | Issue 3 | pp. 257–261Open access
Contingency for Novel Diagnosis and Therapies for Hirschsprung’s Disease
- 1*,
- 1,
- 2,
- 3
- 1 Department of Pharmaceutics, Dayanand Education Society, Dayanand College of Pharmacy, Latur, Maharashtra, INDIA..
- 2 Department of Pharmaceutical Quality Assurance, Dayanand Education Society, Dayanand College of Pharmacy, Latur, Maharashtra, INDIA..
- 3 Department of Pharmacognosy, Dayanand Education Society, Dayanand College of Pharmacy, Latur, Maharashtra, INDIA..
Published in Indian Journal of Pharmacy Practice
Correspondence: Sayali Arun Dongare
Department of Pharmaceutics, Dayanand Education Society, Dayanand College of Pharmacy, Latur, Maharashtra, INDIA..
Email: sayali1622002@gmail.com
- Received:
- Nov 11, 2024
- Accepted:
- Jan 20, 2025
- DOI:
- 10.5530/ijopp.20250219
How to cite
Dongare, S. A., Bastapure, R. S., Lohiya, G. V., & Satpute, K. L. Contingency for Novel Diagnosis and Therapies for Hirschsprung’s Disease. Indian Journal of Pharmacy Practice, 18(3), 257–261. https://doi.org/10.5530/ijopp.20250219
Abstract
The majority of frequent reason of low functional blockage of the bowel in pediatrics is a Hirschsprung disease, which is brought on by a genetic mutation that disrupts the enteric nerve system. The absence of enteric ganglia over a varied length of intestine characterizes this developmental condition, which is classified as a neurocristopathy. Hirschsprung disease is a complicated surgical and medical condition that seems to have different social and health consequences based on the age of the patient and level of neurodevelopment. This review examines the genetic variables that influence development of Hirschsprung disease as well as its prevalence and congenital connection. An overview of a Hirschsprung's disease and its etiology, diagnosis, course of therapy are the goals of this article.
Keywords
Subject
Article metadata
| Title | Contingency for Novel Diagnosis and Therapies for Hirschsprung’s Disease |
|---|---|
| Authors | Sayali Arun Dongare; Rutuja Sunil Bastapure; Gopal Vijaykumar Lohiya; Kranti Limbajirao Satpute |
| Affiliations | Department of Pharmaceutics, Dayanand Education Society, Dayanand College of Pharmacy, Latur, Maharashtra, INDIA..; Department of Pharmaceutical Quality Assurance, Dayanand Education Society, Dayanand College of Pharmacy, Latur, Maharashtra, INDIA..; Department of Pharmacognosy, Dayanand Education Society, Dayanand College of Pharmacy, Latur, Maharashtra, INDIA.. |
| Corresponding author | sayali1622002@gmail.com |
| Journal | Indian Journal of Pharmacy Practice |
| Volume / Issue | Vol. 18, Issue 3 |
Also in this issue
- Assessing the Risk of Brain Tumors in Young Populations: A Reviewpp. 243–248
- Pharmacokinetics, Disease, and Equipment Related Factors Impacting Intensive Care Unit Patient Outcomes: Comprehensive Reviewpp. 249–256
- Maximising Patient Care: The Crucial Role of Clinical Pharmacists in Virtual Hospital and Telehealth Settings: A Reviewpp. 262–265
- A Study of Cost Comparison in Anti-Hypertensive Drugs between Jan Aushadhi’s Generic Drugs and Branded Drugspp. 266–272
- A Prospective Study on the Prescription Pattern of Anti-Epileptic Drugs in Pediatric Patientspp. 273–278